Technion And AMIT Set Up Company For Stem Cell Technology

The Technion – Israel Institute of Technology, alongside the Alfred Mann Institute (AMIT) have founded a company aimed to commercialize stem cell technology developed over the past decade by Professor Joseph Itskovitz-Eldor of the Rappaport institute. The new company, named Accellta, will market technologies and methods which will assist commercial companies and research labs in cultivating stem cells quickly, efficiently and aconomically.